Skip to main content
. Author manuscript; available in PMC: 2013 Nov 21.
Published in final edited form as: J Am Coll Cardiol. 2011 Nov 8;58(20):10.1016/j.jacc.2011.07.042. doi: 10.1016/j.jacc.2011.07.042

Figure 4. Urinary cGMP Excretion After Volume Expansion With BNP Pre-Treatment.

Figure 4

Urinary cyclic guanosine monophosphate (cGMP) excretion in (A) normal control subjects, (B) PSD subjects, and (C) PDD subjects at baseline, 30 min after volume expansion, and 60 min after volume expansion, after placebo (open bars) or subcutaneous B-type natriuretic peptide (SQ BNP) (solid bars) administration. *p < 0.05, ‡p = 0.06, §p = 0.08 versus baseline, and †p < 0.05 versus placebo as measured by t test using a Bonferroni correction for multiple comparisons. Abbreviations as in Figure 1.